KOUNTOUPES DENHAM CARR & REID, LLC for GLENMARK PHARMACEUTICALS, INC., USA
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
General information about the company and the industry. Issues related to affordability and pricing of pharmaceuticals.
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
Health Issues HCR
General education about the generic pharmaceutical industry.
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
Medicare/Medicaid MMM
Issues related to Medicaid CPI Penalty.
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.